Loading clinical trials...
Loading clinical trials...
The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator® Alto in treatment of peripheral artery disease (PAD)...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cagent Vascular LLC
NCT07223593 · Peripheral Arterial Disease
NCT06112171 · Peripheral Arterial Disease
NCT03663777 · Peripheral Arterial Disease
NCT07223437 · Peripheral Arterial Disease
NCT07497360 · Peripheral Arterial Disease
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions